Reuters logo
BRIEF-Nicox FY operating loss narrows to 1.8 million euros
March 31, 2017 / 5:42 AM / 6 months ago

BRIEF-Nicox FY operating loss narrows to 1.8 million euros

March 31 (Reuters) - Nicox SA:

* Cash, cash equivalents and financial instruments of 28.9 million euros as of December 31, 2016, compared to 29.7 million euros on December 31, 2015.

* Group recorded a net loss from continued operations of 6.7 million euros as of December 2016, compared to a net loss of 19.8 million euros at same date in 2015

* FY revenue 16,000 euros versus 67,000 euros year ago

* FY operating loss of 1.8 million euros versus loss of 20.7 million euros year ago

* FY net loss of 19.0 million euros versus loss of 27.9 million euros year ago

* H2 2017: expected launch of Vyzulta (TM)in United States by Bausch + Lomb, subject to FDA approval

* Q3 2017: potential U.S. FDA approval of ZERVIATE NDA

* Q4 2017: start of Phase 2 clinical study for NCX 4251

* Q1 2018: start of Phase 2 clinical study for NCX 470 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below